ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,626,626 | +17.9% | 133,602 | +33.5% | 0.04% | +8.3% |
| Q2 2023 | $3,076,472 | -9.9% | 100,113 | +5.7% | 0.04% | -21.7% |
| Q1 2023 | $3,412,972 | -1.0% | 94,739 | +8.6% | 0.05% | -4.2% |
| Q4 2022 | $3,447,799 | +2.6% | 87,275 | +4.4% | 0.05% | -2.0% |
| Q3 2022 | $3,361,000 | +5.7% | 83,618 | +10.6% | 0.05% | +53.1% |
| Q2 2022 | $3,179,000 | +8.0% | 75,577 | 0.0% | 0.03% | +33.3% |
| Q1 2022 | $2,944,000 | +91.4% | 75,577 | +95.9% | 0.02% | +100.0% |
| Q4 2021 | $1,538,000 | +10.3% | 38,574 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $1,394,000 | – | 38,574 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
| Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
| Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
| HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
| Brown University | 621,759 | $24,777,000 | 6.04% |
| Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
| Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
| Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |